Product overview
Vaccine type
Meningococcal A Conjugate 5 µg
Commercial Name
Meningococcal A Conjugate 5 micrograms MenAfriVac 5µg
Manufacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India
URL
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Vial + Ampoule
Number of Doses
10
Diluent
Specific Meningococcal diluent
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
a.Carton of 50 vials (active)(500 doses) [Dimensions 18.5x9.5x6.0 cm]+ b.carton of 50 ampoules (diluent) [Dimensions 10.5 x 8.7 x 17.0 cm]
Tertiary Packaging
a.Box of 24 cartons of 50 vials (1200 vials/12000 doses) [Dimensions 60x48x41 cm] ; b.Box of 24 cartons of 50 ampoules (diluent) (1200 ampoules/12000 doses) [61x54x53 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.01%
Cold Chain Volume
a. 2.109 (vial); 3.1059(ampoule) cm3/dose (in secondary packaging)
Attachments
